Lavipharm S.A. (ATH:LAVI)

Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	260	164	134	134	64	30
Market Cap Growth	117.05%	22.01%	0.36%	107.29%	117.58%	23.40%
Enterprise Value	287	191	157	161	98	66
Last Close Price	1.54	0.97	0.78	0.78	0.37	1.58
PE Ratio	52.74	27.34	14.93	71.42	77.29	17.20
PS Ratio	4.16	2.62	2.53	2.79	1.65	0.75
PB Ratio	4.61	2.90	2.53	3.12	1.60	-2.98
P/TBV Ratio	17.85	11.22	17.21	78.88	-	-
P/FCF Ratio	48.28	30.35	-	-	-	13.52
P/OCF Ratio	39.07	24.56	29.82	470.51	19.27	7.21
EV/Sales Ratio	4.59	3.06	2.96	3.36	2.50	1.67
EV/EBITDA Ratio	20.93	14.81	17.69	19.44	19.70	12.35
EV/EBIT Ratio	33.28	22.18	31.17	34.11	24.01	14.66
EV/FCF Ratio	53.23	35.47	-	-	-	30.17
Debt / Equity Ratio	0.58	0.58	0.64	0.76	0.92	-3.76
Debt / EBITDA Ratio	2.39	2.39	3.53	3.64	6.68	6.28
Debt / FCF Ratio	6.08	6.08	-	-	-	17.03
Net Debt / Equity Ratio	0.47	0.47	0.54	0.56	0.47	-3.59
Net Debt / EBITDA Ratio	2.07	2.07	3.20	2.91	3.82	6.66
Net Debt / FCF Ratio	4.95	4.95	-5.51	-6.39	-0.59	16.28
Asset Turnover	0.49	0.49	0.44	0.42	0.47	0.77
Inventory Turnover	1.49	1.49	1.52	1.93	2.18	2.70
Quick Ratio	0.65	0.65	0.56	0.66	0.70	0.35
Current Ratio	1.21	1.21	1.15	1.27	1.00	0.63
Return on Equity (ROE)	9.23%	9.23%	18.10%	4.74%	6.25%	-
Return on Assets (ROA)	4.22%	4.22%	2.62%	2.57%	3.04%	5.46%
Return on Invested Capital (ROIC)	6.96%	7.06%	6.79%	4.58%	4.02%	11.00%
Return on Capital Employed (ROCE)	10.00%	10.00%	5.80%	6.00%	5.90%	38.60%
Earnings Yield	2.30%	3.66%	6.70%	1.40%	1.29%	5.82%
FCF Yield	2.07%	3.29%	-3.84%	-2.82%	-50.06%	7.40%
Dividend Yield	1.30%	-	2.58%	-	-	-
Payout Ratio	57.50%	56.48%	-	-	-	-
Buyback Yield / Dilution	0.06%	0.06%	-0.17%	-681.40%	-26.42%	-
Total Shareholder Return	1.36%	0.06%	2.40%	-681.40%	-26.42%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.